文献速递新生儿儿童内分泌与遗传代谢

极早产儿连续血糖监测:新生儿重症监护中的准确性证据

Continuous Glucose Monitoring among Infants Born Very Preterm: Evidence for Accuracy in Neonatal Intensive Care.
PubMed 文献 · J Pediatr · 2024-11-22

该研究评估连续血糖监测(CGM)在胎龄≤32周或出生体重≤1500g的早产儿中的准确性,分析了51名婴儿的501对传感器血糖(SG)与床旁血糖(BG)配对测量。结果显示平均绝对相对差异(MARD)为7.1%,SG与BG差异为-5.6 mg/dL,提示在定期校准下CGM准确性可接受。

要点

  • 在极早产儿中,CGM传感器血糖与床旁血糖的MARD为7.1%,差异微小。
  • 传感器中位使用96小时,每日校准约2次,准确性在临床可接受范围。
  • 研究支持在定期校准条件下,CGM可用于新生儿重症监护的血糖监测。

核心结论

  • 在临床研究环境下,极早产儿连续血糖监测的传感器血糖与床旁血糖准确性可接受,差异可忽略。
  • 定期校准传感器时,传感器血糖的临床使用可能可接受。

研究设计与样本

  • 研究纳入胎龄≤32周或出生体重≤1500g的早产儿,出生48小时内启动CGM并维持5天。
  • 每12小时进行床旁血糖校准,分析传感器血糖与床旁血糖的配对测量以评估准确性。

主要发现

  • 共纳入51名婴儿的501对传感器血糖与床旁血糖配对测量,婴儿中位胎龄30.5周,中位出生体重1400g。
  • 传感器血糖与床旁血糖的平均绝对相对差异(MARD)为7.1%(IQR 5.6-9.3),对应差异为-5.6 mg/dL(95%CI -25至+14 mg/dL)。
  • 传感器中位使用时间为96小时(IQR 72-120),每日校准次数中位为2.0次(IQR 1.7-2.4)。

关键数值与推荐

  • MARD为7.1%(IQR 5.6-9.3),传感器血糖与床旁血糖差异为-5.6 mg/dL(95%CI -25至+14 mg/dL)。
  • 传感器中位使用96小时(IQR 72-120),每日校准2.0次(IQR 1.7-2.4)。

临床怎么用

  • 在新生儿重症监护中,对极早产儿可考虑使用连续血糖监测,但需定期校准以保证准确性。
  • 临床解读传感器血糖时,应结合床旁血糖校准结果,注意个体差异。

局限性

  • 研究为临床研究环境下的准确性评估,样本量有限,结果外推需谨慎。
  • 未报告长期临床结局或与低血糖/高血糖事件的相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the accuracy of a device for continuous glucose monitoring (CGM) among infants born preterm admitted to the neonatal intensive care unit. STUDY DESIGN: We analyzed paired CGM sensor glucose (SG) and point-of-care blood glucose (BG) measurements collected in infants born at ≤32 weeks of gestation or with a birth weight ≤1500 g. CGM was initiated within 48 hours from birth and maintained for 5 days. BG was performed every 12 hours and used to calibrate the sensor. Measures of CGM accuracy were computed from SG and BG pairs. RESULTS: We included 501 SG-BG paired measurements from 51 infants (age 30.5 weeks [IQR 29.0-31.0 weeks], birth weight 1400 g [IQR 1100-1500 g] with at least 24 hours of CGM data. The mean absolute relative difference (MARD) between SG and point-of-care BG measures was 7.1% [IQR 5.6-9.3], corresponding to a difference of -5.6 mg/dL [95% CI -25 to +14 mg/dl]. The median sensor use was 96 hours [IQR 72-120] with 2.0 [IQR 1.7-2.4] calibrations per day. CONCLUSIONS: Accuracy of SG measurements compared with BG measurements appears to be acceptable in a clinical study setting, with a negligible difference between SG and BG. Our data suggest that SG use may be clinically acceptable when the sensor is regularly calibrated.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Bonet J, Guiducci S, Res G, et al. Continuous Glucose Monitoring among Infants Born Very Preterm: Evidence for Accuracy in Neonatal Intensive Care. J Pediatr. 2024. PMID: 39579867. doi:10.1016/j.jpeds.2024.114416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。